These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9152655)

  • 1. Induction of subaortic septal ischaemia to reduce obstruction in hypertrophic obstructive cardiomyopathy. Studies to develop a new catheter-based concept of treatment.
    Kuhn H; Gietzen F; Leuner C; Gerenkamp T
    Eur Heart J; 1997 May; 18(5):846-51. PubMed ID: 9152655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term effects of dual chamber pacing in patients with hypertrophic cardiomyopathy without outflow tract obstruction at rest.
    Gadler F; Linde C; Juhlin-Dannfelt A; Ribeiro A; Rydén L
    Eur Heart J; 1997 Apr; 18(4):636-42. PubMed ID: 9129895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-surgical myocardial reduction in hypertrophic obstructive cardiomyopathy.
    Mutlak D; Gruberg L; Reisner S; Markiewicz W
    Isr Med Assoc J; 2002 Feb; 4(2):86-90. PubMed ID: 11875998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcoronary ablation of septal hypertrophy (TASH): a new treatment option for hypertrophic obstructive cardiomyopathy.
    Kuhn H; Gietzen FH; Leuner C; Schäfers M; Schober O; Strunk-Müller C; Obergassel L; Freick M; Gockel B; Lieder F; Raute-Kreinsen U
    Z Kardiol; 2000; 89 Suppl 4():IV41-54. PubMed ID: 10810776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time to significant gradient reduction following septal balloon occlusion predicts the magnitude of final gradient response during alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy.
    Almasood A; Garceau P; Woo A; Rakowski H; Schwartz L; Overgaard CB
    JACC Cardiovasc Interv; 2011 Sep; 4(9):1030-4. PubMed ID: 21939945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcatheter ablation of septal hypertrophy: a promising alternative to surgery in hypertrophic obstructive cardiomyopathy.
    Keren A; Banai S
    Isr Med Assoc J; 2002 Feb; 4(2):114-6. PubMed ID: 11875983
    [No Abstract]   [Full Text] [Related]  

  • 7. [Percutaneous transluminal septal myocardial ablation: early results and long-term follow-up].
    Tekieli Ł; Pieniazek P; Podolec P; Tomkiewicz-Pajak L; Płazak W; Musiałek P; Leśniak-Sobelga A; Przewłocki T; Biernacka B; Zmudka K; Tracz W
    Przegl Lek; 2006; 63(8):628-32. PubMed ID: 17441371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful coronary stenting of the left anterior descending artery at the branching site of the targeted septal perforator immediately after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy.
    Honda T; Sakamoto T; Miyamoto S; Sugiyama S; Yoshimura M; Ogawa H
    Intern Med; 2005 Jul; 44(7):722-6. PubMed ID: 16093594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of dual-chamber pacing with nonsurgical septal reduction effect in patients with hypertrophic obstructive cardiomyopathy.
    Dimitrow PP; Podolec P; Grodecki J; Płazak W; Dudek D; Pieniazek P; Bacior B; Legutko J; Olszowska M; Kostkiewicz M; Kawecka-Jaszcz K; Tracz W; Dubiel JS
    Int J Cardiol; 2004 Mar; 94(1):31-4. PubMed ID: 14996471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous septal ablation for hypertrophic cardiomyopathy and mid-ventricular obstruction.
    Seggewiss H; Faber L
    Eur J Echocardiogr; 2000 Dec; 1(4):277-80. PubMed ID: 11916606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progressive decrease of outflow gradient and septum thickness after percutaneous alcoholization of the interventricular septum in hypertrophic obstructive cardiomyopathy.
    Airoldi F; Di Mario C; Catanoso A; Dharmadhikari A; Tzifos V; Anzuini A; Carlino M; Briguori C; Montorfano M; Vaghetti M; Tolaro S; Colombo A
    Ital Heart J; 2000 Mar; 1(3):200-6. PubMed ID: 10806987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alcohol septal ablation and the Brockenbrough-Braunwald phenomenon.
    Soon CY; Buergler JM
    Catheter Cardiovasc Interv; 2008 Dec; 72(7):1016-24. PubMed ID: 19021274
    [No Abstract]   [Full Text] [Related]  

  • 13. Mid-systolic septal deceleration. A new sign of left ventricular outflow tract obstruction obtained by color-coded tissue Doppler echocardiography.
    Breithardt OA; Stolle B; Franke A; Janssens U; Hanrath P; Kuhn H
    Z Kardiol; 2003 Dec; 92(12):1003-7. PubMed ID: 14663610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Septal alcoholization in hypertrophic cardiomyopathy: about 11 cases.
    Kambiré Y; Millogo GRC; Dauphin C; Lusson JR
    Pan Afr Med J; 2017; 27():196. PubMed ID: 28904721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Percutaneous transluminal septal ablation with ethanol in hypertrophic obstructive cardiomyopathy: a case report].
    Sakakibara M; Abe S; Fusegawa Y; Nakajima T; Iwata O; Goto S; Shiina Y; Handa S
    J Cardiol; 1999 Jul; 34(1):35-40. PubMed ID: 10422624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left ventricular outflow tract gradient decrease with non-surgical myocardial reduction improves exercise capacity in patients with hypertrophic obstructive cardiomyopathy.
    Ruzyłło W; Chojnowska L; Demkow M; Witkowski A; Kuśmierczyk-Droszcz B; Piotrowski W; Rausinska L; Karcz M; Małecka L; Rydlewska-Sadowska W
    Eur Heart J; 2000 May; 21(9):770-7. PubMed ID: 10739733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute and long-term results after transcoronary ablation of septal hypertrophy (TASH). Catheter interventional treatment for hypertrophic obstructive cardiomyopathy.
    Gietzen FH; Leuner CJ; Raute-Kreinsen U; Dellmann A; Hegselmann J; Strunk-Mueller C; Kuhn HJ
    Eur Heart J; 1999 Sep; 20(18):1342-54. PubMed ID: 10462469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute hemodynamic changes in percutaneous transluminal septal coil embolization for hypertrophic obstructive cardiomyopathy.
    Ramcharitar S; Meliga E; Kirschbaum SW; ten Cate FJ; van Geuns RJ; Serruys PW
    Nat Clin Pract Cardiovasc Med; 2008 Dec; 5(12):806-10. PubMed ID: 18838967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of right ventricular pacing site on left ventricular outflow tract obstruction in patients with hypertrophic obstructive cardiomyopathy.
    Gadler F; Linde C; Juhlin-Dannfeldt A; Ribeiro A; Rydén L
    J Am Coll Cardiol; 1996 Apr; 27(5):1219-24. PubMed ID: 8609346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Percutaneous transluminal ablation of the myocardial septum by embolization of the first branch of the anterior descending coronary artery using a small amount of absolute alcohol].
    Miric M; Sagic D; Popovic Z; Zlatanovic M; Vlahovic A; Vidakovic R; Bojic M
    Srp Arh Celok Lek; 2001; 129(7-8):199-202. PubMed ID: 11797450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.